The use of the fusion protein RGD-HSA-TIMP2 as a tumor targeting imaging probe for SPECT and PET

References

Page 1

	Year	Citations
Requirement of Vascular Integrin α <sub>v</sub> β <sub>3</sub> for Angiogenesis Peter C. Brooks, Richard A.F. Clark, David A. Cheresh Science	1994	3K
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Daniel E. Gómez, Daniel F. Alonso, Hitoshi Yoshiji, PubMed	1997	1.5K
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins Nobuaki Hiraoka, Edward Allen, Ingrid J. Apel, Cell ThrombosisAngiogenesisPericellular FibrinolysinsEndothelial DysfunctionVascular Biology	1998	706
PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles Ha‐Young Lee, Zibo Li, Kai Chen, Journal of Nuclear Medicine	2008	542
TIMP-2 Mediated Inhibition of Angiogenesis Dong Wan Seo, Hongmei Li, Liliana Guédez, Cell AngiogenesisTimp-2 Mediated InhibitionVascular BiologyNeovascularizationMedicine	2003	505
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature Weibo Cai, Kang Chen, Zibo Li, Journal of Nuclear Medicine	2007	424
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. Roland Haubner, Hans‐Jürgen Wester, Ute Reuning, PubMed	1999	356
<b> <i>In vivo</i> </b> Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts Peter S. Conti, Rex Moats Cancer Research	2004	346
18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis Ryan J. Park, Anthony H. Shahinian, Michel Tohme, Nuclear Medicine and Biology Neuro-oncologyEngineeringOncologic ImagingGlioma18F-labeled Rgd Peptide	2004	211
Preparation of a Promising Angiogenesis PET Imaging Agent: <sup>68</sup>Ga-Labeled c(RGDyK)–Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice Jae Min Jeong, Mee Kyung Hong, Young Soo Chang, Journal of Nuclear Medicine	2008	195

Page 1